Trademark Search in Canada

BALVERSA

View On IC.GC.CA

REGISTERED

on 18 Mar 2020

Last Applicant/ Owned by

JOHNSON & JOHNSON

One Johnson & Johnson PlazaNew Brunswick, NJ 08933-7001

Serial Number

1837708 filed on 15^th May 2017

Registration Number

TMA1075417 registered on 18^th Mar 2020

Registration expiry Date

18^th Mar 2030

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

BALVERSA

Trademark usage description

human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases Read More

Classification Information

Class [005]
Human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; anti-viral medications; anti-inflammatory medications; anti-pain medications; and anti-infective medications; human vaccines

Classification kind code

Mark Details

Serial Number

1837708

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 55 on 18^th Mar 2020	Registered
Submitted for opposition 50 on 28^th Sept 2018	Allowed
Submitted for opposition 51 on 28^th Sept 2018	Allowance Notice Sent
Submitted for opposition 42 on 13^th Jun 2018	Advertised
Submitted for opposition 26 on 7^th Jun 2018	Approved
Submitted for opposition 22 on 20^th Apr 2018	Search Recorded
Submitted for opposition 27 on 20^th Apr 2018	Approval Notice Sent
Submitted for opposition 31 on 17^th May 2017	Formalized
Submitted for opposition 1 on 16^th May 2017	Created
Submitted for opposition 30 on 15^th May 2017	Filed